118 related articles for article (PubMed ID: 25315908)
1. SOX2 as prognostic factor in head and neck cancer: a systematic review and meta-analysis.
Li W; Li B; Wang R; Huang D; Jin W; Yang S
Acta Otolaryngol; 2014 Nov; 134(11):1101-8. PubMed ID: 25315908
[TBL] [Abstract][Full Text] [Related]
2. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
3. Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.
Thierauf J; Weissinger SE; Veit JA; Affolter A; Laureano NK; Beutner D; Heiduschka G; Kadletz L; Meyer M; Quaas A; Plinkert P; Hoffmann TK; Hess J
PLoS One; 2018; 13(3):e0194989. PubMed ID: 29596469
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
5. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
Li X; Zhao H; Gu J; Zheng L
Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
[TBL] [Abstract][Full Text] [Related]
9. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
Zhang JM; Wei K; Jiang M
Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].
Jiang XD; Luo G; Wang XH; Chen LL; Ke X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):27-33. PubMed ID: 28072991
[No Abstract] [Full Text] [Related]
11. The association of SOX2 with clinical features and prognosis in colorectal cancer: A meta-analysis.
Zhang XH; Wang W; Wang YQ; Zhu L; Ma L
Pathol Res Pract; 2020 Jan; 216(1):152769. PubMed ID: 31810585
[TBL] [Abstract][Full Text] [Related]
12. SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma.
Tang XB; Shen XH; Li L; Zhang YF; Chen GQ
Auris Nasus Larynx; 2013 Oct; 40(5):481-6. PubMed ID: 23462687
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and prognostic value of CD276 expression in head and neck cancer: A meta-analysis.
Su H; Li N; Chen Z; Hao J; Zhang F
Am J Otolaryngol; 2023; 44(6):103968. PubMed ID: 37442085
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
15. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
[TBL] [Abstract][Full Text] [Related]
16. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
[TBL] [Abstract][Full Text] [Related]
18. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.
Dong Z; Liu G; Huang B; Sun J; Wu D
Int J Clin Exp Med; 2014; 7(12):5010-20. PubMed ID: 25664000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
